The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Inhibin at 90: From Discovery to Clinical Application, a Historical Review
Open accessAbstract
When it was initially discovered in 1923, inhibin was characterized as a hypophysiotropic hormone that acts on pituitary cells to regulate pituitary hormone secretion. Ninety years later, what we know about inhibin stretches far beyond its well-established capacity to inhibit activin signaling and suppress pituitary FSH production. Inhibin is one of the major reproductive hormones involved in the regulation of folliculogenesis and steroidogenesis. Although the physiological role of inhibin as an activin antagonist in other organ systems is not as well defined as it is in the pituitary-gonadal axis, inhibin also modulates biological processes in other organs through paracrine, autocrine, and/or endocrine mechanisms. Inhibin and components of its signaling pathway are expressed in many organs. Diagnostically, inhibin is used for prenatal screening of Down syndrome as part of the quadruple test and as a biochemical marker in the assessment of ovarian reserve. In this review, we provide a comprehensive summary of our current understanding of the biological role of inhibin, its relationship with activin, its signaling mechanisms, and its potential value as a diagnostic marker for reproductive function and pregnancy-associated conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of early loss of pregnancy
Wilcox, A. J., Weinberg, C. R., O'Connor, J. F., Baird, D. D., Schlatterer, J. P., Canfield, R. E., Armstrong, E. G., & Nisula, B. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190401 · Cited by 2,354
FSH Directly Regulates Bone Mass
Sun, L., Peng, Y., Sharrow, A. C., Iqbal, J., Zhang, Z., Papachristou, D. J., Zaidi, S., Zhu, L.-L., Yaroslavskiy, B. B., Zhou, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.051 · Cited by 723
Functional analysis of activins during mammalian development
Matzuk, M. M., Kumar, T. R., Vassalli, A., Bickenbach, J. R., Roop, D. R., Jaenisch, R., & Bradley, A. (1995) · Nature · doi:10.1038/374354a0 · Cited by 578
Sidis, Y., Mukherjee, A., Keutmann, H., Delbaere, A., Sadatsuki, M., & Schneyer, A. (2006) · Endocrinology · doi:10.1210/en.2006-0089 · Cited by 211
Inhibins, activins and follistatin in reproduction
de Kretser, D. M. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.529 · Cited by 211 · cited 1×
“rected to several excellent reviews [14–27]).”
Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00798.2007 · Cited by 183
Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay
Schneyer, A. L., Wang, Q., Sidis, Y., & Sluss, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0162 · Cited by 71
cDNA cloning and expression of human activin βE subunit
Hashimoto, O., Tsuchida, K., Ushiro, Y., Hosoi, Y., Hoshi, N., Sugino, H., & Hasegawa, Y. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00157-0 · Cited by 54
Research works printed but not linked: 537
- McCullagh, 1932, Dual endocrine activity of the testes, Science, 76, 19, 10.1126/science.76.1957.19 · DOI · Paper page
- Mottram, 1923, On the general effects of exposure to radium on metabolism and tumour growth in the rat and the special effects on testis and pituitary, J Exp Physiol, 13, 209, 10.1113/expphysiol.1923.sp000291 · doi:10.1113/expphysiol.1923.sp000291
- Schwartz, 1977, Evidence for ovarian “inhibin”: suppression of the secondary rise in serum follicle stimulating hormone levels in proestrous rats by injection of porcine follicular fluid, Proc Natl Acad Sci USA, 74, 5721, 10.1073/pnas.74.12.5721 · DOI · Paper page
- Keogh, 1976, Selective suppression of FSH by testicular extracts, Endocrinology, 98, 997, 10.1210/endo-98-4-997 · doi:10.1210/endo-98-4-997
- Robertson, 1985, Isolation of inhibin from bovine follicular fluid, Biochem Biophys Res Commun, 126, 220, 10.1016/0006-291X(85)90594-7 · DOI · Paper page
- Rivier, 1985, Purification and partial characterization of inhibin from porcine follicular fluid, Biochem Biophys Res Commun, 133, 120, 10.1016/0006-291X(85)91849-2 · DOI · Paper page
- Ling, 1985, Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid, Proc Natl Acad Sci USA, 82, 7217, 10.1073/pnas.82.21.7217 · DOI · Paper page
- Miyamoto, 1985, Isolation of porcine follicular fluid inhibin of 32K daltons, Biochem Biophys Res Commun, 129, 396, 10.1016/0006-291X(85)90164-0 · DOI · Paper page
- Esch, 1987, Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins, Mol Endocrinol, 1, 388, 10.1210/mend-1-5-388 · DOI · Paper page
- Forage, 1986, Cloning and sequence analysis of cDNA species coding for the two subunits of inhibin from bovine follicular fluid, Proc Natl Acad Sci USA, 83, 3091, 10.1073/pnas.83.10.3091 · DOI · Paper page
- Mason, 1985, Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β, Nature, 318, 659, 10.1038/318659a0 · DOI · Paper page
- Mayo, 1986, Inhibin A-subunit cDNAs from porcine ovary and human placenta, Proc Natl Acad Sci USA, 83, 5849, 10.1073/pnas.83.16.5849 · DOI · Paper page
- Woodruff, 1987, Rat inhibin: molecular cloning of α- and β-subunit complementary deoxyribonucleic acids and expression in the ovary, Mol Endocrinol, 1, 561, 10.1210/mend-1-8-561 · DOI · Paper page
- Burger, 2001, The inhibins and ovarian cancer, Mol Cell Endocrinol, 180, 145, 10.1016/S0303-7207(01)00519-6 · doi:10.1016/s0303-7207(01)00519-6
- de Kretser, 2001, Inhibins, activins and follistatin: actions on the testis, Mol Cell Endocrinol, 180, 87, 10.1016/S0303-7207(01)00502-0 · DOI
- Hillier, 1993, Inhibin, activin, and follistatin. Potential roles in ovarian physiology, Ann N Y Acad Sci, 687, 29, 10.1111/j.1749-6632.1993.tb43850.x · DOI
- Jaffe, 1993, Activins and inhibins: gonadal peptides during prenatal development and adult life, Ann N Y Acad Sci, 687, 1, 10.1111/j.1749-6632.1993.tb43846.x · doi:10.1111/j.1749-6632.1993.tb43846.x
- Lambert-Messerlian, 2004, Inhibins and activins in human fetal abnormalities, Mol Cell Endocrinol, 225, 101, 10.1016/j.mce.2004.02.019 · DOI
- Makanji, 2011, Feedback regulation by inhibins A and B of the pituitary secretion of follicle-stimulating hormone, Vitam Horm, 85, 299, 10.1016/B978-0-12-385961-7.00014-7 · DOI
- Mather, 1992, Paracrine regulation of reproductive function by inhibin and activin, Proc Soc Exp Biol Med, 201, 1, 10.3181/00379727-201-43473 · DOI · Paper page
- Matzuk, 1996, Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development, Recent Prog Horm Res, 51, 123
- Mayo, 1994, Inhibin and activin molecular aspects of regulation and function, Trends Endocrinol Metab, 5, 407, 10.1016/1043-2760(95)92523-L · DOI
- McNeilly, 2012, Diagnostic applications for inhibin and activins, Mol Cell Endocrinol, 359, 121, 10.1016/j.mce.2011.06.017 · doi:10.1016/j.mce.2011.06.017
- Petraglia, 1991, Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy, Am J Obstet Gynecol, 165, 750, 10.1016/0002-9378(91)90323-J · doi:10.1016/0002-9378(91)90323-j
- Qu, 1995, Inhibin and activin production in human placenta, Endocr Rev, 16, 485, 10.1210/edrv-16-4-485 · DOI
- Robertson, 2012, Inhibins and activins in blood: predictors of female reproductive health?, Mol Cell Endocrinol, 359, 78, 10.1016/j.mce.2011.05.016 · doi:10.1016/j.mce.2011.05.016
- De Jong, 1976, Evidence for inhibin-like activity in bovine follicular fluid, Nature, 263, 71, 10.1038/263071a0 · DOI · Paper page
- Setchell, 1974, Inhibin-like activity in rete testis fluid, J Endocrinol, 62, 675, 10.1677/joe.0.0620675 · DOI
- Woodruff, 1990, Inhibin and activin locally regulate rat ovarian folliculogenesis, Endocrinology, 127, 3196, 10.1210/endo-127-6-3196 · DOI · Paper page
- Hsueh, 1987, Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis, Proc Natl Acad Sci USA, 84, 5082, 10.1073/pnas.84.14.5082 · DOI · Paper page
- Baly, 1993, Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum, Endocrinology, 132, 2099, 10.1210/endo.132.5.8477659 · doi:10.1210/endo.132.5.8477659
- Betteridge, 1991, A two-site enzyme-linked immunosorbent assay for inhibin, Biol Reprod, 45, 748, 10.1095/biolreprod45.5.748 · doi:10.1095/biolreprod45.5.748
- Wong, 1993, Monoclonal antibody based ELISAs for measurement of activins in biological fluids, J Immunol Methods, 165, 1, 10.1016/0022-1759(93)90100-L · DOI
- Woodruff, 1993, Quantitative two-site enzyme-linked immunosorbent assays for inhibin A, activin A and activin B, Hum Reprod, 8, 133, 10.1093/humrep/8.suppl_2.133 · doi:10.1093/humrep/8.suppl_2.133
- Chari, 1976, A convenient and rapid bioassay for inhibin, Horm Res, 7, 129, 10.1159/000178720 · doi:10.1159/000178720
- Nandini, 1976, A model system for studying inhibin, Endocrinology, 98, 1460, 10.1210/endo-98-6-1460 · doi:10.1210/endo-98-6-1460
- Ramasharma, 1979, A rapid bioassay for measuring inhibin activity, Biol Reprod, 20, 831, 10.1095/biolreprod20.4.831 · doi:10.1095/biolreprod20.4.831
- de Jong, 1979, Bioassay of inhibin-like activity using pituitary cells in vitro, J Endocrinol, 80, 91, 10.1677/joe.0.0800091 · doi:10.1677/joe.0.0800091
- Eddie, 1979, A bioassay for inhibin using pituitary cell cultures, J Endocrinol, 81, 49, 10.1677/joe.0.0810049 · DOI
- Hudson, 1979, Bioassays for inhibin: a critical review, J Reprod Fertil Suppl, 26, 17
- Scott, 1980, A simple and rapid in vitro bioassay for inhibin, Endocrinology, 107, 1536, 10.1210/endo-107-5-1536 · DOI · Paper page
- Leversha, 1987, Isolation of inhibin from ovine follicular fluid, J Endocrinol, 113, 213, 10.1677/joe.0.1130213 · DOI
- Good, 1995, Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin, Biol Reprod, 53, 1478, 10.1095/biolreprod53.6.1478 · doi:10.1095/biolreprod53.6.1478
- Ireland, 1994, Alterations in amounts of different forms of inhibin during follicular atresia, Biol Reprod, 50, 1265, 10.1095/biolreprod50.6.1265 · doi:10.1095/biolreprod50.6.1265
- Knight, 1989, Evidence that the bovine ovary secretes large amounts of monomeric inhibin α subunit and its isolation from bovine follicular fluid, J Mol Endocrinol, 2, 189, 10.1677/jme.0.0020189 · doi:10.1677/jme.0.0020189
- Miyamoto, 1986, Demonstration of high molecular weight forms of inhibin in bovine follicular fluid (bFF) by using monoclonal antibodies to bFF 32K inhibin, Biochem Biophys Res Commun, 136, 1103, 10.1016/0006-291X(86)90447-X · doi:10.1016/0006-291x(86)90447-x
- Sugino, 1992, Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid, Endocrinology, 130, 789
- Moore, 1994, Initial characterization of equine inhibin, Biol Reprod, 51, 63, 10.1095/biolreprod51.1.63 · doi:10.1095/biolreprod51.1.63
- Grootenhuis, 1990, Inhibin in immature rat Sertoli cell conditioned medium: a 32 kDa α β-B dimer, Mol Cell Endocrinol, 70, 109, 10.1016/0303-7207(90)90064-F · DOI
- Hancock, 1992, Inhibin and inhibin α-chain precursors are produced by immature rat Sertoli cells in culture, Biol Reprod, 46, 155, 10.1095/biolreprod46.1.155 · DOI
- Noguchi, 1997, Ontogeny of inhibin secretion in the rat testis: secretion of inhibin-related proteins from fetal Leydig cells and of bioactive inhibin from Sertoli cells, J Endocrinol, 155, 27, 10.1677/joe.0.1550027 · DOI
- Majumdar, 1997, A study of the relative roles of follicle-stimulating hormone and luteinizing hormone in the regulation of testicular inhibin secretion in the rhesus monkey (Macaca mulatta), Endocrinology, 138, 1363, 10.1210/endo.138.4.5058 · doi:10.1210/endo.138.4.5058
- Winters, 1999, Partial characterization of circulating inhibin-B and pro-αC during development in the male rhesus monkey, Endocrinology, 140, 5497, 10.1210/endo.140.12.7167 · DOI
- Robertson, 1996, Biological and immunological characterization of inhibin forms in human plasma, J Clin Endocrinol Metab, 81, 669
- Robertson, 1997, The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma, J Clin Endocrinol Metab, 82, 889
- Findlay, 1989, Immunisation against the amino-terminal peptide (α N) of the α 43 subunit of inhibin impairs fertility in sheep, Endocrinology, 124, 3122, 10.1210/endo-124-6-3122 · doi:10.1210/endo-124-6-3122
- Robertson, 1986, Isolation of a 31 kDa form of inhibin from bovine follicular fluid, Mol Cell Endocrinol, 44, 271, 10.1016/0303-7207(86)90133-4 · DOI
- McLachlan, 1986, The radioimmunoassay of bovine and human follicular fluid and serum inhibin, Mol Cell Endocrinol, 46, 175, 10.1016/0303-7207(86)90096-1 · doi:10.1016/0303-7207(86)90096-1
- McLachlan, 1987, Circulating immunoreactive inhibin levels during the normal human menstrual cycle, J Clin Endocrinol Metab, 65, 954, 10.1210/jcem-65-5-954 · DOI · Paper page
- Groome, 1990, Monoclonal and polyclonal antibodies reactive with the 1–32 amino terminal sequence of the α subunit of human 32K inhibin, Hybridoma, 9, 31, 10.1089/hyb.1990.9.31 · DOI
- Groome, 1994, Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay, Clin Endocrinol (Oxf), 40, 717, 10.1111/j.1365-2265.1994.tb02504.x · DOI · Paper page
- Groome, 1996, Measurement of dimeric inhibin B throughout the human menstrual cycle, J Clin Endocrinol Metab, 81, 1401
- Groome, 1991, Preparation of monoclonal antibodies to the β A subunit of ovarian inhibin using a synthetic peptide immunogen, Hybridoma, 10, 309, 10.1089/hyb.1991.10.309 · DOI
- Knight, 1996, Development and application of a two-site enzyme immunoassay for the determination of ‘total’ activin-A concentrations in serum and follicular fluid, J Endocrinol, 148, 267, 10.1677/joe.0.1480267 · DOI · Paper page
- Knight, 1994, Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin, J Endocrinol, 141, 417, 10.1677/joe.0.1410417 · doi:10.1677/joe.0.1410417
- Ludlow, 2008, Development of a new antibody to the human inhibin/activin βB subunit and its application to improved inhibin B ELISAs, J Immunol Methods, 329, 102, 10.1016/j.jim.2007.09.013 · doi:10.1016/j.jim.2007.09.013
- Robertson, 2001, Development of an inhibin α subunit ELISA with broad specificity, Mol Cell Endocrinol, 180, 79, 10.1016/S0303-7207(01)00518-4 · doi:10.1016/s0303-7207(01)00518-4
- Robertson, 2002, Characterization of inhibin forms and their measurement by an inhibin α-subunit ELISA in serum from postmenopausal women with ovarian cancer, J Clin Endocrinol Metab, 87, 816
- Ling, 1986, Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin, Nature, 321, 779, 10.1038/321779a0 · DOI · Paper page
- Vale, 1986, Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid, Nature, 321, 776, 10.1038/321776a0 · DOI · Paper page
- Ling, 1986, A homodimer of the β-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone, Biochem Biophys Res Commun, 138, 1129, 10.1016/S0006-291X(86)80400-4 · DOI · Paper page
- Mason, 1989, Activin B: precursor sequences, genomic structure and in vitro activities, Mol Endocrinol, 3, 1352, 10.1210/mend-3-9-1352 · DOI
- H tten, 1995, Cloning of a new member of the TGF-β family: a putative new activin β C chain, Biochem Biophys Res Commun, 206, 608, 10.1006/bbrc.1995.1086 · DOI · Paper page
- Lau, 2000, Activin βC and βE genes are not essential for mouse liver growth, differentiation, and regeneration, Mol Cell Biol, 20, 6127, 10.1128/MCB.20.16.6127-6137.2000 · DOI
- Gold, 2009, Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo, Am J Pathol, 174, 184, 10.2353/ajpath.2009.080296 · DOI
- Makanji, 2009, Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin A in vitro and in vivo, Endocrinology, 150, 4784, 10.1210/en.2008-1783 · DOI
- Woodruff, 1993, Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. I. Serum profile of rh-inhibin A and rh-activin A in the immature female rat, Endocrinology, 132, 715, 10.1210/endo.132.2.8425490 · DOI
- Woodruff, 1993, Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats, Endocrinology, 132, 725, 10.1210/endo.132.2.8425491 · DOI
- Mason, 1996, Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A, Mol Endocrinol, 10, 1055
- Woodruff, 1990, Regulation of inhibin synthesis in the rat ovary, Annu Rev Physiol, 52, 807, 10.1146/annurev.ph.52.030190.004111 · DOI
- Esch, 1987, Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad, Mol Endocrinol, 1, 849, 10.1210/mend-1-11-849 · DOI · Paper page
- Mason, 1986, Structure of two human ovarian inhibins, Biochem Biophys Res Commun, 135, 957, 10.1016/0006-291X(86)91021-1 · DOI · Paper page
- Gray, 1990, Requirement for activin A and transforming growth factor–β 1 pro-regions in homodimer assembly, Science, 247, 1328, 10.1126/science.2315700 · DOI · Paper page
- Antenos, 2008, An activin/furin regulatory loop modulates the processing and secretion of inhibin α- and βB-subunit dimers in pituitary gonadotrope cells, J Biol Chem, 283, 33059, 10.1074/jbc.M804190200 · DOI
- Antenos, 2011, Role of PCSK5 expression in mouse ovarian follicle development: identification of the inhibin α- and β-subunits as candidate substrates, PLoS One, 6, e17348, 10.1371/journal.pone.0017348 · DOI
- Hauburger, 2009, The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding, FEBS J, 276, 6386, 10.1111/j.1742-4658.2009.07361.x · DOI
- Jasuja, 2007, Bone morphogenetic protein 1 prodomain specifically binds and regulates signaling by bone morphogenetic proteins 2 and 4, J Biol Chem, 282, 9053, 10.1074/jbc.M610929200 · DOI
- Gregory, 2005, The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix, J Biol Chem, 280, 27970, 10.1074/jbc.M504270200 · DOI · Paper page
- Thies, 2001, GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding, Growth Factors, 18, 251, 10.3109/08977190109029114 · DOI · Paper page
- Makanji, 2007, Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan, Endocrinology, 148, 2309, 10.1210/en.2006-1612 · DOI
- Antenos, 2007, N-linked oligosaccharides direct the differential assembly and secretion of inhibin α- and βA-subunit dimers, Mol Endocrinol, 21, 1670, 10.1210/me.2007-0050 · DOI
- Walton, 2009, A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor β (TGFβ) ligands, J Biol Chem, 284, 9311, 10.1074/jbc.M808763200 · DOI
- Barton, 1989, Mapping of genes for inhibin subunits α, β A, and β B on human and mouse chromosomes and studies of jsd mice, Genomics, 5, 91, 10.1016/0888-7543(89)90091-8 · doi:10.1016/0888-7543(89)90091-8
- Stewart, 1986, Human inhibin genes. Genomic characterisation and sequencing, FEBS Lett, 206, 329, 10.1016/0014-5793(86)81006-7 · doi:10.1016/0014-5793(86)81006-7
- Debieve, 2002, Control of the human inhibin α chain promoter in cytotrophoblast cells differentiating into syncytium, Mol Hum Reprod, 8, 262, 10.1093/molehr/8.3.262 · doi:10.1093/molehr/8.3.262
- Su, 1992, Characterization of mouse inhibin α gene and its promoter, Biochem Biophys Res Commun, 186, 293, 10.1016/S0006-291X(05)80806-X · doi:10.1016/s0006-291x(05)80806-x
- Walton, 2011, The synthesis and secretion of inhibins, Vitam Horm, 85, 149, 10.1016/B978-0-12-385961-7.00008-1 · DOI
- Vidal, 1992, Identification and mapping of six microdissected genomic DNA probes to the proximal region of mouse chromosome 1, Genomics, 14, 32, 10.1016/S0888-7543(05)80279-4 · DOI
- Justice, 1990, A molecular genetic linkage map of mouse chromosome 13 anchored by the beige (bg) and satin (sa) loci, Genomics, 6, 341, 10.1016/0888-7543(90)90575-F · DOI
- Tanimoto, 1996, Human activin βA gene. Identification of novel 5′ exon, functional promoter, and enhancers, J Biol Chem, 271, 32760, 10.1074/jbc.271.51.32760 · DOI
- Tanimoto, 1991, Structure and sequence analysis of the human activin β A subunit gene, DNA Seq, 2, 103, 10.3109/10425179109039678 · DOI
- Erämaa, 1992, Developmental and cyclic adenosine 3′,5′monophosphate-dependent regulation of inhibin subunit messenger ribonucleic acids in human fetal testes, J Clin Endocrinol Metab, 75, 806
- Dykema, 1994, Two messenger ribonucleic acids encoding the common β B-chain of inhibin and activin have distinct 5′-initiation sites and are differentially regulated in rat granulosa cells, Endocrinology, 135, 702, 10.1210/endo.135.2.8033818 · doi:10.1210/endo.135.2.8033818
- Feng, 1989, Analysis of the 5′-flanking regions of rat inhibin α- and β-B-subunit genes suggests two different regulatory mechanisms, Mol Endocrinol, 3, 1914, 10.1210/mend-3-12-1914 · DOI
- Robert, 2006, LRH-1/NR5A2 cooperates with GATA factors to regulate inhibin α-subunit promoter activity, Mol Cell Endocrinol, 257–258, 65, 10.1016/j.mce.2006.06.011 · DOI
- Tremblay, 2001, GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements, Endocrinology, 142, 977, 10.1210/endo.142.3.7995 · doi:10.1210/endo.142.3.7995 · Paper page
- Bicsak, 1986, Hormonal regulation of granulosa cell inhibin biosynthesis, Endocrinology, 119, 2711, 10.1210/endo-119-6-2711 · DOI · Paper page
- Tsonis, 1987, Production of inhibin bioactivity by human granulosa-lutein cells: stimulation by LH and testosterone in vitro, J Endocrinol, 112, R11, 10.1677/joe.0.112R011 · DOI
- Conti, 2002, Specificity of the cyclic adenosine 3′,5′-monophosphate signal in granulosa cell function, Biol Reprod, 67, 1653, 10.1095/biolreprod.102.004952 · DOI · Paper page
- Richards, 2001, New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells, Mol Endocrinol, 15, 209
- Ito, 2000, Synergistic activation of the inhibin α-promoter by steroidogenic factor-1 and cyclic adenosine 3′,5′-monophosphate, Mol Endocrinol, 14, 66
- Mukherjee, 1996, Gonadotropins induce rapid phosphorylation of the 3′,5′-cyclic adenosine monophosphate response element binding protein in ovarian granulosa cells, Endocrinology, 137, 3234, 10.1210/endo.137.8.8754745 · doi:10.1210/endo.137.8.8754745
- Pei, 1991, Regulation of the α inhibin gene by cyclic adenosine 3′,5′-monophosphate after transfection into rat granulosa cells, Mol Endocrinol, 5, 521, 10.1210/mend-5-4-521 · doi:10.1210/mend-5-4-521
- Ardekani, 1998, Structure of the rat inhibin and activin βA-subunit gene and regulation in an ovarian granulosa cell line, Endocrinology, 139, 3271, 10.1210/endo.139.7.6116 · DOI
- Matulis, 2012, The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells, Mol Endocrinol, 26, 1278, 10.1210/me.2011-1347 · DOI
- Weck, 2006, Switching of NR5A proteins associated with the inhibin α-subunit gene promoter after activation of the gene in granulosa cells, Mol Endocrinol, 20, 1090, 10.1210/me.2005-0199 · DOI
- Woodruff, 1988, Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle, Science, 239, 1296, 10.1126/science.3125611 · DOI · Paper page
- Camp, 1991, Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary, Mol Endocrinol, 5, 1405, 10.1210/mend-5-10-1405 · DOI · Paper page
- Hickey, 1988, Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: relationship to estradiol biosynthesis, Endocrinology, 122, 1426, 10.1210/endo-122-4-1426 · DOI · Paper page
- Ronen-Fuhrmann, 1998, Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary, Endocrinology, 139, 303, 10.1210/endo.139.1.5694 · DOI · Paper page
- Meldi, 2012, DNA methylation and histone modifications are associated with repression of the inhibin α promoter in the rat corpus luteum, Endocrinology, 153, 4905, 10.1210/en.2012-1292 · DOI
- Lenton, 1991, Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles, J Clin Endocrinol Metab, 73, 1180, 10.1210/jcem-73-6-1180 · DOI
- Burkart, 2006, Mechanism of repression of the inhibin α-subunit gene by inducible 3′,5′-cyclic adenosine monophosphate early repressor, Mol Endocrinol, 20, 584, 10.1210/me.2005-0204 · DOI
- Burkart, 2005, Repression of the inhibin α-subunit gene by the transcription factor CCAAT/enhancer-binding protein-β, Endocrinology, 146, 1909, 10.1210/en.2004-0842 · DOI
- Daopin, 1992, Crystal structure of transforming growth factor-β 2: an unusual fold for the superfamily, Science, 257, 369, 10.1126/science.1631557 · DOI · Paper page
- Hart, 2002, Crystal structure of the human TβR2 ectodomain–TGF-β3 complex, Nat Struct Biol, 9, 203
- Groppe, 2008, Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding, Mol Cell, 29, 157, 10.1016/j.molcel.2007.11.039 · DOI · Paper page
- Thompson, 2003, Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions, EMBO J, 22, 1555, 10.1093/emboj/cdg156 · DOI · Paper page
- Greenwald, 2004, A flexible activin explains the membrane-dependent cooperative assembly of TGF-β family receptors, Mol Cell, 15, 485, 10.1016/j.molcel.2004.07.011 · DOI
- Lin, 2006, The structural basis of TGF-β, bone morphogenetic protein, and activin ligand binding, Reproduction, 132, 179, 10.1530/rep.1.01072 · DOI
- Kirsch, 2000, Crystal structure of the BMP-2-BRIA ectodomain complex, Nat Struct Biol, 7, 492, 10.1038/75903 · DOI · Paper page
- Nickel, 2001, The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists, J Bone Joint Surg Am, 83-A, S7
- Allendorph, 2007, BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors, Biochemistry, 46, 12238, 10.1021/bi700907k · DOI
- Saremba, 2008, Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand, FEBS J, 275, 172, 10.1111/j.1742-4658.2007.06187.x · DOI
- Greenwald, 2003, The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly, Mol Cell, 11, 605, 10.1016/S1097-2765(03)00094-7 · DOI · Paper page
- Brown, 2005, Crystal structure of BMP-9 and functional interactions with pro-region and receptors, J Biol Chem, 280, 25111, 10.1074/jbc.M503328200 · DOI · Paper page
- Cash, 2009, The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding, EMBO J, 28, 2662, 10.1038/emboj.2009.205 · DOI · Paper page
- Vitt, 2001, Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules, Mol Endocrinol, 15, 681, 10.1210/mend.15.5.0639 · doi:10.1210/mend.15.5.0639 · Paper page
- Mason, 1994, Functional analysis of the cysteine residues of activin A, Mol Endocrinol, 8, 325
- Harrington, 2006, Structural basis for the inhibition of activin signalling by follistatin, EMBO J, 25, 1035, 10.1038/sj.emboj.7601000 · DOI · Paper page
- Thompson, 2005, The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding, Dev Cell, 9, 535, 10.1016/j.devcel.2005.09.008 · DOI · Paper page
- Zhu, 2010, Phylogenomic analyses reveal the evolutionary origin of the inhibin α-subunit, a unique TGFβ superfamily antagonist, PLoS One, 5, e9457, 10.1371/journal.pone.0009457 · DOI
- Attisano, 2002, Signal transduction by the TGF-β superfamily, Science, 296, 1646, 10.1126/science.1071809 · DOI · Paper page
- Gray, 2000, Identification of a binding site on the type II activin receptor for activin and inhibin, J Biol Chem, 275, 3206, 10.1074/jbc.275.5.3206 · DOI
- Greenwald, 1999, Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase, Nat Struct Biol, 6, 18, 10.1038/4887 · DOI
- Wuytens, 1999, Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors, J Biol Chem, 274, 9821, 10.1074/jbc.274.14.9821 · DOI
- Harrison, 2003, Identification of a functional binding site for activin on the type I receptor ALK4, J Biol Chem, 278, 21129, 10.1074/jbc.M302015200 · DOI
- Mathews, 1991, Expression cloning of an activin receptor, a predicted transmembrane serine kinase, Cell, 65, 973, 10.1016/0092-8674(91)90549-E · DOI · Paper page
- del Re, 2004, Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system, J Biol Chem, 279, 53126, 10.1074/jbc.M408090200 · DOI
- Kupershmidt, 2007, The neuroprotective effect of activin A and B: implication for neurodegenerative diseases, J Neurochem, 103, 962, 10.1111/j.1471-4159.2007.04785.x · DOI
- Tsuchida, 2004, Activin isoforms signal through type I receptor serine/threonine kinase ALK7, Mol Cell Endocrinol, 220, 59, 10.1016/j.mce.2004.03.009 · DOI
- Bertolino, 2008, Activin B receptor ALK7 is a negative regulator of pancreatic β-cell function, Proc Natl Acad Sci USA, 105, 7246, 10.1073/pnas.0801285105 · DOI
- Ferguson, 1998, Activin is an essential early mesenchymal signal in tooth development that is required for patterning of the murine dentition, Genes Dev, 12, 2636, 10.1101/gad.12.16.2636 · DOI · Paper page
- Vassalli, 1994, Activin/inhibin β B subunit gene disruption leads to defects in eyelid development and female reproduction, Genes Dev, 8, 414, 10.1101/gad.8.4.414 · DOI · Paper page
- Schrewe, 1994, Mice homozygous for a null mutation of activin β B are viable and fertile, Mech Dev, 47, 43, 10.1016/0925-4773(94)90094-9 · DOI
- Matzuk, 1995, Different phenotypes for mice deficient in either activins or activin receptor type II, Nature, 374, 356, 10.1038/374356a0 · DOI · Paper page
- Oh, 1997, The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse, Genes Dev, 11, 1812, 10.1101/gad.11.14.1812 · DOI · Paper page
- Gu, 1998, The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse, Genes Dev, 12, 844, 10.1101/gad.12.6.844 · DOI · Paper page
- Jörnvall, 2001, The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line, J Biol Chem, 276, 5140, 10.1074/jbc.M005200200 · DOI
- Brown, 2000, Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions, Nat Genet, 25, 453, 10.1038/78161 · DOI · Paper page
- McNeilly, 2002, Production of inhibin A not B in rams: changes in plasma inhibin A during testis growth, and expression of inhibin/activin subunit mRNA and protein in adult testis, Reproduction, 123, 827, 10.1530/rep.0.1230827 · doi:10.1530/rep.0.1230827
- Barakat, 2008, Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice, Reproduction, 136, 345, 10.1530/REP-08-0140 · doi:10.1530/rep-08-0140
- Takehara-Kasamatsu, 2007, Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development, J Med Invest, 54, 276, 10.2152/jmi.54.276 · DOI
- Wang, 2004, Developmental profiles of activin βA, βB, and follistatin expression in the zebrafish ovary: evidence for their differential roles during sexual maturation and ovulatory cycle, Biol Reprod, 71, 2056, 10.1095/biolreprod.104.032649 · DOI
- Phillips, 2001, New developments in the biology of inhibins, activins and follistatins, Trends Endocrinol Metab, 12, 94, 10.1016/S1043-2760(01)00376-9 · DOI
- Kocamis, 1999, The ontogeny of myostatin, follistatin and activin-B mRNA expression during chicken embryonic development, Growth Dev Aging, 63, 143
- Glister, 2004, Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin, Reproduction, 127, 239, 10.1530/rep.1.00090 · DOI · Paper page
- Schneyer, 2008, Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin, Endocrinology, 149, 4589, 10.1210/en.2008-0259 · DOI
- Ueno, 1987, Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone, Proc Natl Acad Sci USA, 84, 8282, 10.1073/pnas.84.23.8282 · DOI · Paper page
- Robertson, 1987, The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin, Biochem Biophys Res Commun, 149, 744, 10.1016/0006-291X(87)90430-X · DOI · Paper page
- Lima, 2010, Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure, Int J Exp Pathol, 91, 54, 10.1111/j.1365-2613.2009.00683.x · DOI
- Ogawa, 1993, Expression of α, β A and β B subunits of inhibin or activin and follistatin in rat pancreatic islets, FEBS Lett, 319, 217, 10.1016/0014-5793(93)80549-A · DOI
- Petraglia, 1994, Local production and action of follistatin in human placenta, J Clin Endocrinol Metab, 78, 205
- Inoue, 1994, Localization of follistatin, an activin-binding protein, in bone tissues, Calcif Tissue Int, 55, 395, 10.1007/BF00299321 · DOI
- Michel, 2000, Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis, Eur J Endocrinol, 143, 809, 10.1530/eje.0.1430809 · DOI
- Sonoyama, 2000, Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells, Am J Physiol Gastrointest Liver Physiol, 278, G89, 10.1152/ajpgi.2000.278.1.G89 · DOI
- Bloise, 2009, Differential expression of follistatin and FLRG in human breast proliferative disorders, BMC Cancer, 9, 320, 10.1186/1471-2407-9-320 · DOI
- Shimasaki, 1988, Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing, Biochem Biophys Res Commun, 152, 717, 10.1016/S0006-291X(88)80097-4 · DOI
- Sugino, 1993, Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell, J Biol Chem, 268, 15579, 10.1016/S0021-9258(18)82296-7 · DOI · Paper page
- Hashimoto, 1997, A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate, J Biol Chem, 272, 13835, 10.1074/jbc.272.21.13835 · DOI · Paper page
- Lerch, 2007, Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions, J Biol Chem, 282, 15930, 10.1074/jbc.M700737200 · DOI
- Harrison, 2005, Antagonists of activin signaling: mechanisms and potential biological applications, Trends Endocrinol Metab, 16, 73, 10.1016/j.tem.2005.01.003 · DOI · Paper page
- Keutmann, 2004, The role of follistatin domains in follistatin biological action, Mol Endocrinol, 18, 228, 10.1210/me.2003-0112 · DOI
- Harrison, 2006, Activin-A binds follistatin and type II receptors through overlapping binding sites: generation of mutants with isolated binding activities, Endocrinology, 147, 2744, 10.1210/en.2006-0131 · DOI
- Kaiser, 1992, Follistatin gene expression in the pituitary: localization in gonadotropes and folliculostellate cells in diestrous rats, Endocrinology, 130, 3048, 10.1210/endo.130.5.1572312 · DOI
- Schneyer, 2003, Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG), Endocrinology, 144, 1671, 10.1210/en.2002-0203 · DOI
- Matzuk, 1995, Multiple defects and perinatal death in mice deficient in follistatin, Nature, 374, 360, 10.1038/374360a0 · DOI · Paper page
- Lin, 2008, Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms, Mol Endocrinol, 22, 415, 10.1210/me.2006-0529 · DOI
- Kimura, 2010, The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice, Endocrinology, 151, 1310, 10.1210/en.2009-1176 · DOI
- Kimura, 2011, Follistatin regulates germ cell nest breakdown and primordial follicle formation, Endocrinology, 152, 697, 10.1210/en.2010-0950 · DOI
- Jorgez, 2004, Granulosa cell-specific inactivation of follistatin causes female fertility defects, Mol Endocrinol, 18, 953, 10.1210/me.2003-0301 · DOI · Paper page
- Schneyer, 2001, Follistatin-related protein (FSRP): a new member of the follistatin gene family, Mol Cell Endocrinol, 180, 33, 10.1016/S0303-7207(01)00501-9 · DOI
- Tortoriello, 2001, Human follistatin-related protein: a structural homologue of follistatin with nuclear localization, Endocrinology, 142, 3426, 10.1210/endo.142.8.8319 · DOI
- Xia, 2004, Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice, Mol Endocrinol, 18, 979, 10.1210/me.2003-0364 · DOI
- Tsuchida, 2000, Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family, J Biol Chem, 275, 40788, 10.1074/jbc.M006114200 · DOI · Paper page
- Sidis, 2005, Heparin and activin-binding determinants in follistatin and FSTL3, Endocrinology, 146, 130, 10.1210/en.2004-1041 · DOI
- Hill, 2003, Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains, Mol Endocrinol, 17, 1144, 10.1210/me.2002-0366 · DOI · Paper page
- Maguer-Satta, 2003, Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFβ family, Exp Cell Res, 282, 110, 10.1016/S0014-4827(02)00013-7 · DOI
- Otsuka, 2001, Follistatin inhibits the function of the oocyte-derived factor BMP-15, Biochem Biophys Res Commun, 289, 961, 10.1006/bbrc.2001.6103 · DOI
- Ciarmela, 2003, Human placenta and fetal membranes express follistatin-related gene mRNA and protein, J Endocrinol Invest, 26, 641, 10.1007/BF03347022 · DOI
200 of 537 shown
Cited by
The hypothalamus-pituitary-gonad axis: Tales of mice and men
Kaprara, A., & Huhtaniemi, I. T. (2018) · Metabolism · doi:10.1016/j.metabol.2017.11.018 · Cited by 329
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
“We call attention to a recent, extensive review of the inhibins, which includes their historical, biological, and clinical importance (Makanji et al. 2014).”
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031261 · Cited by 79
“It circulates in three isoforms: Fst288, Fst303 and Fst301 [84,85].”
BackgroundEffects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing
Farr, J. N., Roforth, M. M., Fujita, K., Nicks, K. M., Cunningham, J. M., Atkinson, E. J., Therneau, T. M., McCready, L. K., Peterson, J. M., Drake, M. T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138347 · Cited by 75
Perakakis, N., Mougios, V., Fatouros, I., Siopi, A., Draganidis, D., Peradze, N., Ghaly, W., & Mantzoros, C. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01056 · Cited by 52
Michael, I. P., Saghafinia, S., Tichet, M., Zangger, N., Marinoni, I., Perren, A., & Hanahan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.015 · Cited by 42
Papathanasiou, A. E., Nolen-Doerr, E., Farr, O. M., & Mantzoros, C. S. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0847 · Cited by 20
Metadata
- Authors
- Makanji, Y., Zhu, J., Mishra, R., Holmquist, C., Wong, W. P. S., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2014-07-22
- Volume
- 35
- Issue
- 5
- Pages
- 747-794
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2111843622
- Cited by
- 186
- References
- 8
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.